Aug 09, 2016 10:26 am UTC| Business
- Ended Second Quarter with $47.5 million in Cash - SHANGHAI, China and CUPERTINO, Calif., Aug. 09, 2016 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firm...
EV Energy Partners Announces Second Quarter 2016 Results
Aug 09, 2016 10:19 am UTC| Business
HOUSTON, Aug. 09, 2016 -- EV Energy Partners, L.P. (NASDAQ:EVEP) today announced results for the second quarter of 2016 and the filing of its Form 10-Q with the Securities and Exchange Commission. Second Quarter 2016...
Aug 09, 2016 10:05 am UTC| Business
ANN ARBOR, Mich., Aug. 09, 2016 -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has completed the buildout of its new Indiana...
Achillion to Present at the 2016 Wedbush PacGrow Healthcare Conference
Aug 09, 2016 10:05 am UTC| Business
NEW HAVEN, Conn., Aug. 09, 2016 -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at the...
Aug 09, 2016 10:00 am UTC| Business
Total Net Revenue, modified for working capital adjustments related to New York acquisitions, (“Adjusted Revenue”), increased 10.0% to $224.6 million in the second quarter of 2016 from $204.3 million in the second quarter...
APAC In Vitro Diagnostics Market Worth $33.4 Billion By 2024: Grand View Research, Inc.
Aug 09, 2016 10:00 am UTC| Business
San Francisco, Aug. 09, 2016 -- The Asia Pacific In Vitro Diagnostics (IVD) market is expected to reach USD 33.4 billion by 2024, according to a new report by Grand View Research, Inc. The Asia Pacific IVD market is...
Aeglea BioTherapeutics Announces Second Quarter 2016 Financial Results
Aug 09, 2016 10:00 am UTC| Business
AUSTIN, Texas, Aug. 09, 2016 -- Aeglea BioTherapeutics, Inc., (NASDAQ:AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare diseases and...